Analytical Instrument & Life Science Market Insights

Pharma/Bio Trends Supporting Demand for Analytical Instrumentation

October 25, 2021/in Blog, Featured Articles 3 /by Amethyst Holder

Implementing the appropriate laboratory instrumentation to support therapeutic development is crucial to the process of drug discovery. Life science and analytical instrumentation facilitates pharmaceutical R&D throughout these stages. SDi has observed the dynamics of the pharma/bio sector demand for instrumentation to support innovative biologics, small molecule drugs, regenerative pharmaceuticals, and biopharmaceuticals. Most of these drug […]

Trends in the Laboratory Instrument Service Market

September 29, 2021/in Blog /by Ivan Gandayuwana

The servicing of analytical and life science instrumentation is vital to maintaining instrument performance capabilities and maximizing the life of costly lab assets. Whether provided by the original instrument manufacturer or by a third-party service provider, the instrument service market includes all service contracts and any replacement parts installed during servicing. Other services like software […]

Mesa Labs acquisition of Agena Bioscience shows importance of clinical diagnostic systems

September 24, 2021/in Blog /by Wes Bova

Clinical laboratory diagnostics has become an important area of investment and business transactions. Recently, Mesa Laboratories, a biotech company focused on quality control solutions for pharmaceutical, healthcare, and medical devices, announced the acquisition of Agena Bioscience for a cash purchase price of $300 million. According to the press release, Mesa is expected to pay for […]

Laboratory Consumables a Major Area of Industry Acquisition Activity

August 31, 2021/in Blog /by Michael Tice

While M&A and IPO activity tends to ebb and flow in the laboratory industry, the current trend seems to be on the upswing. Just over the past few weeks, there seems to be a hotbed of activity particularly in the area of laboratory consumables. Most notably, near the end of July, PerkinElmer announced a $5.25 […]

Cell & Gene Therapies: CROs and CMOs Bridge the Gap from Innovation to Approval

May 7, 2021/in Blog /by Alice Kan

Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, with promising developments expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others as well. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge […]

Next Generation Sequencing, Diagnostics, and COVID Variants

April 5, 2021/in Blog /by Amethyst Holder

Testing has been at the forefront of public health efforts and challenges since the beginning of the pandemic caused by SARS-CoV-2, the virus responsible for COVID-19 disease. By April last year, it became increasingly clear that testing would be crucial to public health and safety. However, global testing capacities substantially lagged behind demand as shortages […]

COVID-19 Testing at the Community Level – Digital PCR is a Key Tool

March 30, 2021/in Blog /by Alice Kan

This month marked the anniversary of the World Health Organization’s declaration of the SARS-CoV-2 outbreak as a pandemic. Virtually all aspects of normal life and business were quickly disrupted by the novel and deadly coronavirus as it spread across the world. But researchers and the analytical instrumentation companies that supply them rose to the occasion. […]

Instrument Business Outlook Releases Forecast Issue

January 21, 2021/in Blog /by Justin Dudash

Instrument Business Outlook estimates the Analytical Instruments and Lab Products Industry is expected to grow at 9.4% in 2021. Is your business best positioned to take advantage of opportunities in this massive market? That’s the results from the 2021 IBO Annual Review and Industry Forecast Issue as an accurate source for predictions, news, and information […]

Google’s DeepMind Makes a Quantum Leap in Solving the Protein Folding Problem

December 10, 2020/in Blog /by Michael Tice

Artificial Intelligence has made something of a breakthrough in the prediction of protein structures. The results came about as part of the 14th Critical Assessment of Structure Prediction, a friendly contest and conference organized by the Protein Structure Prediction Center with sponsorship from the US NIH’s National Institute of General Medical Sciences (NIH/NIGMS). The challengers […]

The Top Three High-Tech Research Areas Driving Instrument Sales in Academia

December 8, 2020/in Blog /by Ryan Harake

The academic market for lab instrumentation encompasses university research labs, core labs, non-profit research institutes, and clinical research activities performed at university hospitals. It is the single largest end market for instrument sales. Unfortunately, the COVID-19 pandemic halted many academic lab operations in 2020 due to mandatory and self-imposed shutdowns, which has resulted in a […]

Lens On The Scientific Market

Pharma/Bio Trends Supporting Demand for Analytical Instrumentation

Trends in the Laboratory Instrument Service Market

Mesa Labs acquisition of Agena Bioscience shows importance of clinical diagnostic systems

Laboratory Consumables a Major Area of Industry Acquisition Activity

Cell & Gene Therapies: CROs and CMOs Bridge the Gap from Innovation to Approval

Next Generation Sequencing, Diagnostics, and COVID Variants

COVID-19 Testing at the Community Level – Digital PCR is a Key Tool

Instrument Business Outlook Releases Forecast Issue

Google’s DeepMind Makes a Quantum Leap in Solving the Protein Folding Problem

The Top Three High-Tech Research Areas Driving Instrument Sales in Academia

Contact Us

Pay Invoice

Press Releases

Sitemap

Your Data and Privacy

About Us